Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Dynamics Special Purpose $601 million combination with Senti Biosciences
We are advising Dynamics, a SPAC, on the transaction
Focus Financial Partners $176 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Strategic Value Partners tender offer for Washington Prime Group stapled units
We advised Strategic Value Partners on the cash tender offer by two funds it manages
Ancestry.com $250 million senior notes offering
The high-yield notes are due 2028
Swiftmerge Acquisition $200 million IPO
The issuer, a SPAC, offered 20,000,000 units which were listed on Nasdaq
MoneyLion acquisition of Even Financial
We advised MoneyLion on the transaction
BeiGene RMB22.2 billion Shanghai IPO
The offering, equivalent to $3.5 billion, is the largest biotech IPO to date in 2021
Forbion European Acquisition $126.5 million IPO
We advised Forbion European Acquisition, a SPAC, on its IPO and Nasdaq listing
Net Protections ¥67.7 billion IPO
The shares are listed on the Tokyo Stock Exchange
Rentokil Initial $6.7 billion acquisition of Terminix Global Holdings
We are advising Rentokil Initial on the transaction